Effect of pulsatile IV insulin delivery on circulating risk markers of vascular and metabolic complications in pts with type 1 and type 2 diabetes.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 09 Aug 2016 Biomarkers information updated
- 18 Aug 2009 Planned end date changed from 1 Feb 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 18 Aug 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.